Policy Title | Policy Number | Effective Date |
---|
Abaloparatide (Tymlos) (PDF) | CP.PHAR.345 | July 1, 2017 |
Abametapir (Xeglyze) (PDF) | CP.PMN.253 | December 1, 2020 |
Abemaciclib (Verzenio) (PDF) | CP.PHAR.355 | October 24, 2017 |
Abiraterone (Zytiga,
Yonsa) (PDF) | CP.PHAR.84 | October 1, 2011 |
AbobotulinumtoxinA (Dysport) (PDF) | CP.PHAR.230 | July 1, 2016 |
Abrocitinib (Cibinqo) (PDF) | CP.PHAR.578 | June 1, 2022 |
Acalabrutinib (Calquence) (PDF) | CP.PHAR.366 | March 1, 2018 |
Acyclovir Buccal Tablet (Sitavig) (PDF) | CP.PMN.210 | September 1, 2019 |
Adefovir (Hepsera) (PDF) | CP.PHAR.142 | August 28, 2018 |
Ado-Trastuzumab Emtansine (Kadcyla) (PDF) | CP.PHAR.229 | June 1, 2016 |
Aducanumab-avwa (Aduhelm) (PDF) | CP.PHAR.468 | June 1, 2020 |
Afamelanotide (Scenesse) (PDF) | CP.PHAR.444 | March 1, 2020 |
Afatinib (Gilotrif) (PDF) | CP.PHAR.298 | January 1, 2017 |
Aflibercept (Eylea) (PDF) | CP.PHAR.184 | March 1, 2016 |
Agalsidase Beta (Fabrazyme) (PDF) | CP.PHAR.158 | February 1, 2016 |
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) | CP.PMN.138 | March 13, 2018 |
Alectinib (Alecensa) (PDF) | CP.PHAR.369 | November 16, 2016 |
Alemtuzumab (Lemtrada) (PDF) | CP.PHAR.243 | August 1, 2016 |
Alendronate (Binosto, Fosamax Plus D) (PDF) | CP.PMN.88 | February 28, 2018 |
Alglucosidase Alfa (Lumizyme) (PDF) | CP.PHAR.160 | February 1, 2016 |
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF) | CP.PHAR.562 | March 1, 2022 |
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF) | CP.PHAR.563 | March 1, 2022 |
Alpelisib (Piqray, Vijoice) (PDF) | CP.PHAR.430 | September 1, 2019 |
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF) | CP.PHAR.94 | March 1, 2012 |
Amantadine ER (Gocovri, Osmolex ER) | CP.PMN.89 | October 10, 2017 |
Ambrisentan (Letairis) (PDF) | CP.PHAR.190 | March 1, 2016 |
Amifampridine (Firdapse) (PDF) | CP.PHAR.411 | January 22, 2019 |
Amikacin (Arikayce) (PDF) | CP.PHAR.401 | November 13, 2018 |
Amisulpride (Barhemsys) (PDF) | CP.PMN.236 | September 1, 2020 |
Amivantamab-vmjw (Rybrevant) (PDF) | CP.PHAR.544 | September 1, 2021 |
Anifrolumab-fnia (Saphnelo) (PDF) | CP.PHAR.551 | December 1, 2021 |
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) | CP.PHAR.217 | May 1, 2016 |
Antithrombin III (ATryn, Thrombate III) (PDF) | CP.PHAR.564 | March 1, 2022 |
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) | CP.PHAR.506 | December 1, 2020 |
Apalutamide (Erleada) (PDF) | CP.PCH.45 | March 1, 2022 |
Apomorphine (Apokyn, Kynmobi) (PDF) | CP.PHAR.488 | September 1, 2020 |
Aprepitant (Emend, Cinvanti), Fosaprepitant (Emend for injection) (PDF) | CP.PMN.19 | November 30, 2016 |
Aprepitant (Emend, Cinvanti), Fosaprepitant (Emend for injection) (PDF) | CP.PMN.19 | November 30, 2016 |
Aripiprazole Long-Acting Injections (Abilify Maintena, Aristada, Aristada Initio) (PDF) | CP.PHAR.290 | December 1, 2016 |
Aripiprazole Orally Disintegrating Tablet (PDF) | CP.PCH.37 | March 1, 2021 |
Armodafinil (Nuvigil) (PDF) | CP.PMN.35 | August 1, 2009 |
Asciminib (Scemblix) (PDF) | CP.PHAR.565 | March 1, 2022 |
Asenapine (Saphris, Secuado) (PDF) | CP.PMN.15 | December 1, 2014 |
Asfotase Alfa (Strensiq) (PDF) | CP.PHAR.328 | March 1, 2017 |
Aspirin/Dipyridamole (Aggrenox) (PDF) | CP.PMN.20 | September 1, 2006 |
Atezolizumab (Tecentriq) (PDF) | CP.PHAR.235 | June 1, 2016 |
Atogepant (Qulipta) (PDF) | CP.PHAR.566 | March 1, 2022 |
Avacopan (Tavneos) (PDF) | CP.PHAR.515 | March 1, 2021 |
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) | CP.PHAR.521 | March 1, 2021 |
Avapritinib (Ayvakit) (PDF) | CP.PHAR.454 | March 1, 2020 |
Avatrombopag (Doptelet) (PDF) | CP.PHAR.130 | July 17, 2018 |
Avelumab (Bavencio) (PDF) | CP.PHAR.333 | May 1, 2017 |
Axicabtagene Ciloleucel (Yescarta) (PDF) | CP.PHAR.362 | October 31, 2017 |
Axitinib (Inlyta) (PDF) | CP.PHAR.100 | May 1, 2012 |
Azacitidine (Onureg, Vidaza) (PDF) | CP.PHAR.387 | August 28, 2018 |
Azelaic Acid (Finacea Topical Gel/Foam) (PDF) | HIM.PA.119 | November 9, 2017 |
Aztreonam (Cayston) (PDF) | CP.PHAR.209 | May 1, 2016 |
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) | CP.PHAR.149 | November 9, 2017 |
Baloxavir Marboxil (Xofluza) (PDF) | CP.PMN.185 | October 30, 2018 |
Bedaquiline (Sirturo) (PDF) | CP.PMN.212 | December 1, 2019 |
Belantamab Mafodotin-blmf (Blenrep) (PDF) | CP.PHAR.469 | June 1, 2020 |
Belatacept (Nulojix) (PDF) | CP.PHAR.201 | November 9, 2017 |
Belimumab (Benlysta) (PDF) | CP.PHAR.88 | October 1, 2011 |
Belinostat (Beleodaq) (PDF) | CP.PHAR.311 | February 1, 2017 |
Belumosudil (Rezurock) (PDF) | CP.PHAR.552 | December 1, 2021 |
Belzutifan (Welireg) (PDF) | CP.PHAR.553 | December 1, 2021 |
Bempedoic Acid (Nexletol), Bempedoic Acid/Ezetimibe (Nexlizet) (PDF) | CP.PMN.237 | September 1, 2020 |
Bendamustine (Belrapzo, Bendeka, Treanda) (PDF) | CP.PHAR.307 | February 1, 2017 |
Benralizumab (Fasenra) (PDF) | CP.PHAR.373 | January 16, 2018 |
Benznidazole (PDF) | CP.PMN.90 | October 17, 2017 |
Betaine (Cystadane) (PDF) | CP.PHAR.143 | August 28, 2018 |
Betamethasone Dipropionate Spray (Sernivo) (PDF) | CP.PMN.182 | December 1, 2018 |
Betibeglogene Autotemcel (Zynteglo) (PDF) | CP.PHAR.545 | September 1, 2021 |
Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) (PDF) | CP.PHAR.93 | October 31, 2011 |
Bexarotene (Targretin Capsules, Gel) (PDF) | CP.PHAR.75 | September 1, 2011 |
Bezlotoxumab (Zinplava) (PDF) | CP.PHAR.300 | November 16, 2016 |
Bimatoprost Implant (Durysta) (PDF) | CP.PHAR.486 | June 1, 2020 |
Binimetinib (Mektovi) (PDF) | CP.PHAR.50 | July 24, 2018 |
Biologic and Non-biologic DMARDs (PDF) | HIM.PA.SP60 | January 1, 2020 |
Blinatumomab (Blincyto) (PDF) | CP.PHAR.312 | February 1, 2017 |
Bortezomib (Velcade) (PDF) | CP.PHAR.410 | December 11, 2018 |
Bosentan (Tracleer) (PDF) | CP.PHAR.191 | March 1, 2016 |
Bosutinib (Bosulif) (PDF) | CP.PHAR.105 | October 1, 2012 |
Brand Name Override and Non-Formulary Medications (PDF) | HIM.PA.103 | December 1, 2014 |
Brentuximab Vedotin (Adcetris) (PDF) | CP.PHAR.303 | February 1, 2017 |
Brexanolone (Zulresso) (PDF) | CP.PHAR.417 | April 16, 2019 |
Brexpiprazole (Rexulti) (PDF) | CP.PMN.68 | November 5, 2015 |
Brexucabtagene Autoleucel (Tecartus) (PDF) | CP.PHAR.472 | June 1, 2020 |
Brigatinib (Alunbrig) (PDF) | CP.PHAR.342 | July 17, 2017 |
Brimonidine Tartrate (Mirvaso) (PDF) | CP.PMN.192 | November 15, 2016 |
Brinzolamide/Brimonidine (Simbrinza) (PDF) | HIM.PA.15 | September 4, 2018 |
Brivaracetam (Briviact) (PDF) | CP.PCH.26 | May 21, 2019 |
Brolucizumab-dbll (Beovu) (PDF) | CP.PHAR.445 | February 29, 2020 |
Budesonide (Tarpeyo) (PDF) | CP.PHAR.572 | March 1, 2022 |
Budesonide (Uceris) (PDF) | CP.PCH.11 | August 14, 2018 |
Buprenorphine (Subutex) (PDF) | CP.PMN.82 | September 1, 2017 |
Buprenorphine Implant/Injection (Probuphine, Sublocade) (PDF) | CP.PHAR.289 | November 16, 2016 |
Buprenorphine/Naloxone (Bunavail, Cassipa, Suboxone, Zubsolv) (PDF) | CP.PMN.81 | September 1, 2017 |
Bupropion/Naltrexone (Contrave) (PDF) | CP.PCH.12 | May 1, 2017 |
Burosumab-twza (Crysvita) (PDF) | CP.PHAR.11 | May 8, 2018 |
Butorphanol Nasal Spray (PDF) | HIM.PA.46 | December 1, 2014 |
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) | CP.PHAR.202 | March 1, 2016 |
Cabazitaxel (Jevtana) (PDF) | CP.PHAR.316 | February 1, 2017 |
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF) | CP.PHAR.573 | March 1, 2022 |
Cabozantinib (Cabometyx, Cometriq) (PDF) | CP.PHAR.111 | June 1, 2013 |
Calcifediol (Rayaldee) (PDF) | CP.PMN.76 | November 1, 2016 |
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) | CP.PMN.181 | December 1, 2018 |
Canakinumab (Ilaris) (PDF) | CP.PHAR.246 | August 1, 2016 |
Cannabidiol (Epidiolex) (PDF) | CP.PMN.164 | July 17, 2018 |
Capecitabine (Xeloda) (PDF) | CP.PHAR.60 | May 1, 2011 |
Caplacizumab-yhdp (Cablivi) (PDF) | CP.PHAR.416 | March 12, 2019 |
Capmatinib (Tabrecta) (PDF) | CP.PHAR.494 | September 1, 2020 |
Carbidopa/Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy) (PDF) | CP.PMN.238 | September 1, 2020 |
Carfilzomib (Kyprolis) (PDF) | CP.PHAR.309 | February 1, 2017 |
Carglumic Acid (Carbaglu) (PDF) | CP.PHAR.206 | May 1, 2016 |
Cariprazine (Vraylar) (PDF) | CP.PMN.91 | November 16, 2016 |
Casimersen (Amondys 45) (PDF) | CP.PHAR.470 | June 1, 2020 |
Casirivimab and Imdevimab (REGEN-COV) (PDF) | CP.PHAR.520 | December 22, 2020 |
Celecoxib (Celebrex, Elyxyb) (PDF) | CP.PMN.122 | January 1, 2007 |
Cemiplimab-rwlc (Libtayo) (PDF) | CP.PHAR.397 | October 16, 2018 |
Cenegermin-bkbj (Oxervate) (PDF) | CP.PMN.186 | October 9, 2018 |
Cenobamate (Xcopri) (PDF) | CP.PMN.231 | March 1, 2020 |
Ceritinib (Zykadia) (PDF) | CP.PHAR.349 | July 1, 2017 |
Cerliponase Alfa (Brineura) (PDF) | CP.PHAR.338 | July 1, 2017 |
Cetuximab (Erbitux) (PDF) | CP.PHAR.317 | February 1, 2017 |
Chenodiol (Chenodal) (PDF) | CP.PMN.239 | September 1, 2020 |
Chlorambucil (Leukeran) (PDF) | CP.PHAR.554 | December 1, 2021 |
Chloramphenicol Sodium Succinate (PDF) | CP.PHAR.388 | December 1, 2018 |
Cholic Acid (Cholbam) (PDF) | CP.PHAR.390 | December 1, 2018 |
Ciclopirox (Penlac) (PDF) | CP.PMN.24 | September 1, 2007 |
Ciltacabtagene Autoleucel (Carvykti) (PDF) | CP.PHAR.533 | May 7, 2021 |
Cinacalcet (Sensipar) (PDF) | CP.PHAR.61 | May 1, 2011 |
Ciprofloxacin/Dexamethasone (Ciprodex) (PDF) | CP.PMN.248 | December 1, 2020 |
Ciprofloxacin/Fluocinolone (Otovel) (PDF) | CP.PMN.249 | December 1, 2020 |
Cladribine (Mavenclad) (PDF) | CP.PHAR.422 | September 1, 2019 |
Clascoterone (Winlevi) (PDF) | CP.PMN.257 | February 28, 2021 |
Clinical Policy: Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF) | CP.PHAR.260 | July 1, 2016 |
Clobazam (Onfi, Sympazan) (PDF) | CP.PMN.54 | November 1, 2012 |
CNS Stimulants (PDF) | CP.PMN.92 | March 1, 2018 |
Cobimetinib (Cotellic) (PDF) | CP.PHAR.380 | November 16, 2016 |
Colesevelam (Welchol) (PDF) | CP.PMN.250 | December 1, 2020 |
Collagenase Clostridium Histolyticum (Xiaflex) (PDF) | CP.PHAR.82 | October 1, 2011 |
Colonoscopy Preparation Products (PDF) | CP.PCH.43 | December 1, 2021 |
Compounded Medications (PDF) | CP.PMN.280 | September 1, 2022 |
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) | CP.PMN.258 | March 1, 2021 |
Continuous Glucose Monitors (PDF) | CP.PMN.214 | December 1, 2019 |
Copanlisib (Aliqopa) (PDF) | CP.PHAR.357 | October 17, 2017 |
Corticosteroids
for Ophthalmic Injection (Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF) | CP.PHAR.385 | May 29, 2018 |
Cosyntropin (Cortrosyn) (PDF) | CP.PHAR.203 | April 1, 2016 |
Crisaborole (Eucrisa) (PDF) | CP.PMN.110 | February 21, 2017 |
Crizanlizumab-tmca (Adakveo) (PDF) | CP.PHAR.449 | March 1, 2020 |
Crizanlizumab-tmca (Adakveo) (PDF) | CP.PHAR.449 | March 1, 2020 |
Crizotinib (Xalkori) (PDF) | CP.PHAR.90 | November 1, 2011 |
Cyclosporine (Cequa, Restasis, Verkazia) (PDF) | CP.PMN.48 | May 1, 2012 |
Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF) | CP.PMN.130 | August 1, 2017 |
Cysteamine oral (Cystagon, Procysbi) (PDF) | CP.PHAR.155 | February 1, 2016 |
Cytomegalovirus Immune Globulin (CytoGam) (PDF) | CP.PHAR.277 | September 1, 2018 |
Dabrafenib (Tafinlar) (PDF) | CP.PHAR.239 | November 16, 2016 |
Dacomitinib (Vizimpro) (PDF) | CP.PHAR.399 | October 16, 2018 |
Dalfampridine (Ampyra) (PDF) | CP.PHAR.248 | August 1, 2016 |
Dalteparin (Fragmin) (PDF) | CP.PHAR.225 | May 1, 2016 |
Dapsone (Aczone Gel) (PDF) | CP.PCH.32 | December 1, 2020 |
Daptomycin (Cubicin, Cubicin RF) (PDF) | CP.PHAR.351 | November 30, 2017 |
Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) | CP.PHAR.310 | July 1, 2017 |
Darbepoetin Alfa (Aranesp) (PDF) | CP.PHAR.236 | June 1, 2016 |
Darolutamide (Nubeqa) (PDF) | CP.PHAR.435 | December 1, 2019 |
Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir (Viekira Pak) (PDF) | HIM.PA.SP61 | August 1, 2020 |
Dasatinib (Sprycel) (PDF) | CP.PHAR.72 | June 1, 2012 |
Daunorubicin/Cytarabine (Vyxeos) (PDF) | CP.PHAR.352 | December 1, 2017 |
Decitabine/Cedazuridine (Inqovi) (PDF) | CP.PHAR.479 | June 1, 2020 |
Deferasirox (Exjade, Jadenu) (PDF) | CP.PHAR.145 | November 1, 2015 |
Deferoxamine (Desferal) (PDF) | CP.PHAR.146 | November 1, 2015 |
Deflazacort (Emflaza) (PDF) | CP.PHAR.331 | March 1, 2017 |
Degarelix Acetate (Firmagon) (PDF) | CP.PHAR.170 | November 9, 2017 |
Delafloxacin (Baxdela) (PDF) | CP.PMN.115 | November 9, 2017 |
Denosumab (Prolia, Xgeva) (PDF) | CP.PHAR.58 | March 1, 2011 |
Desmopressin Acetate (DDAVP, Stimate, Nocdurna, Noctiva) (PDF) | CP.PHAR.214 | May 1, 2016 |
Deutetrabenazine (Austedo) (PDF) | CP.PCH.42 | June 1, 2021 |
Dexlansoprazole (Dexilant) (PDF) | HIM.PA.05 | January 1, 2020 |
Dexrazoxane (Totect) (PDF) | CP.PHAR.418 | March 19, 2019 |
Dextromethorphan/Bupropion (Auvelity) (PDF) | CP.PMN.284 | December 1, 2022 |
Dextromethorphan-Quinidine (Nuedexta) (PDF) | CP.PMN.93 | March 1, 2018 |
Diazepam Nasal Spray (Valtoco) (PDF) | CP.PMN.216 | December 1, 2019 |
Dichlorphenamide (Keveyis) (PDF) | CP.PMN.261 | March 1, 2021 |
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) | CP.PCH.28 | September 1, 2020 |
Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF) | CP.PCH.41 | February 1, 2021 |
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (PDF) | HIM.PA.58 | March 1, 2018 |
Dolasetron (Anzemet) (PDF) | CP.PMN.141 | September 1, 2006 |
Dornase Alfa (Pulmozyme) (PDF) | CP.PHAR.212 | May 1, 2016 |
Dostarlimab-gxly (Jemperli) (PDF) | CP.PHAR.540 | September 1, 2021 |
Doxepin (Silenor, Prudoxin, Zonalon) (PDF) | HIM.PA.147 | November 17, 2017 |
Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF) | CP.PMN.79 | May 1, 2017 |
Dupilumab (Dupixent) (PDF) | CP.PHAR.336 | May 1, 2017 |
Durvalumab (Imfinzi) (PDF) | CP.PHAR.339 | July 1, 2017 |
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) | CP.PMN.128 | May 1, 2016 |
Duvelisib (Copiktra) (PDF) | CP.PHAR.400 | October 16, 2018 |
Ecallantide (Kalbitor) (PDF) | CP.PHAR.177 | March 1, 2016 |
Eculizumab (Soliris) (PDF) | CP.PHAR.97 | March 1, 2012 |
Edaravone (Radicava, Radivaca ORS) (PDF) | CP.PHAR.343 | July 1, 2017 |
Efgartigimod Alfa-fcab (Vyvgart) (PDF) | CP.PHAR.555 | December 1, 2021 |
Efinaconazole (Jublia) (PDF) | CP.PMN.25 | August 1, 2016 |
Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) (PDF) | CP.PHAR.136 | August 28, 2018 |
Elapegademase-lvlr (Revcovi) (PDF) | CP.PHAR.419 | April 23, 2019 |
Elbasvir/Grazoprevir (Zepatier) (PDF) | HIM.PA.SP62 | August 1, 2020 |
Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) (PDF) | CP.PHAR.440 | December 1, 2019 |
Eliglustat (Cerdelga) (PDF) | CP.PHAR.153 | February 1, 2016 |
Elivaldogene Autotemcel (Skysona) (PDF) | CP.PHAR.556 | December 1, 2021 |
Elosulfase Alfa (Vimizim) (PDF) | CP.PHAR.162 | February 1, 2016 |
Elotuzumab (Empliciti) (PDF) | CP.PHAR.308 | February 1, 2017 |
Eltrombopag (Promacta) (PDF) | CP.PHAR.180 | March 1, 2016 |
Eluxadoline (Viberzi) (PDF) | CP.PMN.170 | December 1, 2018 |
Emapalumab-lzsg (Gamifant) (PDF) | CP.PHAR.402 | December 11, 2018 |
Emicizumab-kxwh (Hemlibra) (PDF) | CP.PHAR.370 | March 1, 2018 |
Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF) | CP.PMN.235 | June 1, 2020 |
Enasidenib (Idhifa) (PDF) | CP.PHAR.363 | September 5, 2017 |
Encorafenib (Braftovi) (PDF) | CP.PHAR.127 | July 24, 2018 |
Enfortumab Vedotin-ejfv (Padcev) (PDF) | CP.PHAR.455 | March 1, 2020 |
Enfuvirtide (Fuzeon) (PDF) | CP.PHAR.41 | June 1, 2010 |
Enoxaparin (Lovenox) (PDF) | CP.PHAR.224 | May 1, 2016 |
Entecavir (Baraclude) (PDF) | HIM.PA.08 | February 19, 2019 |
Entrectinib (Rozlytrek) (PDF) | CP.PHAR.441 | December 1, 2019 |
Enzalutamide (Xtandi) (PDF) | HIM.PA.164 | March 1, 2022 |
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) | CP.PHAR.237 | June 1, 2016 |
Epoprostenol (Flolan, Veletri) (PDF) | CP.PHAR.192 | March 1, 2016 |
Eptinezumab-jjmr (Vyepti) (PDF) | HIM.PA.SP64 | October 1, 2020 |
Erdafitinib (Balversa) (PDF) | CP.PHAR.423 | September 1, 2019 |
Erenumab-aaoe (Aimovig) (PDF) | HIM.PA.SP65 | October 1, 2020 |
Eribulin Mesylate (Halaven) (PDF) | CP.PHAR.318 | March 1, 2017 |
Erlotinib (Tarceva) (PDF) | CP.PHAR.74 | September 1, 2011 |
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF) | CP.PHAR.301 | February 1, 2017 |
Esketamine (Spravato) (PDF) | CP.PMN.199 | March 12, 2019 |
Estradiol Vaginal Ring (Femring) (PDF) | CP.PMN.263 | January 1, 2022 |
Etelcalcetide (Parsabiv) (PDF) | CP.PHAR.379 | March 20, 2018 |
Eteplirsen (Exondys 51) (PDF) | CP.PHAR.288 | December 1, 2016 |
Everolimus (Afinitor, Afinitor Disperz, Zortress) (PDF) | CP.PHAR.63 | June 1, 2011 |
Evinacumab-dgnb (Evkeeza) (PDF) | CP.PHAR.511 | December 1, 2020 |
Evolocumab (Repatha) (PDF) | HIM.PA.156 | June 1, 2021 |
Factor IX (Human, Recombinant) (PDF) | CP.PHAR.218 | May 1, 2016 |
Factor IX Complex, Human (Profilnine) (PDF) | CP.PHAR.219 | May 1, 2016 |
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) | CP.PHAR.220 | May 1, 2016 |
Factor VIII (Human, Recombinant) (PDF) | CP.PHAR.215 | May 1, 2016 |
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) | CP.PHAR.216 | May 1, 2016 |
Factor XIII A-Subunit, Recombinant (Tretten) (PDF) | CP.PHAR.222 | May 1, 2016 |
Factor XIII, Human (Corifact) (PDF) | CP.PHAR.221 | May 1, 2016 |
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF) | CP.PHAR.456 | March 1, 2020 |
Faricimab-svoa (Vabysmo) (PDF) | CP.PHAR.581 | June 1, 2022 |
Febuxostat (Uloric) (PDF) | CP.PMN.57 | August 1, 2013 |
Fedratinib (Inrebic) (PDF) | CP.PHAR.442 | December 1, 2019 |
Fenfluramine (Fintepla) | CP.PMN.246 | September 1, 2020 |
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF) | CP.PMN.127 | June 1, 2015 |
Ferric Carboxymaltose (Injectafer) (PDF) | CP.PHAR.234 | June 1, 2016 |
Ferric Derisomaltose (Monoferric) (PDF) | CP.PHAR.480 | June 1, 2020 |
Ferric Gluconate (Ferrlecit) (PDF) | CP.PHAR.166 | March 1, 2016 |
Ferric Maltol (Accrufer) (PDF) | CP.PMN.213 | December 1, 2019 |
Ferumoxytol (Feraheme) (PDF) | CP.PHAR.165 | March 1, 2016 |
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF) | CP.PHAR.526 | June 1, 2021 |
Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko) (PDF) | CP.PHAR.297 | December 1, 2016 |
Finerenone (Kerendia) (PDF) | CP.PMN.266 | December 1, 2021 |
Fingolimod (Gilenya, Tascenso ODT) (PDF) | CP.PCH.38 | February 1, 2021 |
Flibanserin (Addyi) (PDF) | CP.PHAR.446 | March 1, 2020 |
Fluorouracil Cream (Tolak) (PDF) | CP.PMN.165 | December 1, 2018 |
Fluticasone Propionate (Xhance) (PDF) | CP.PMN.95 | October 24, 2017 |
Fondaparinux (Arixtra) (PDF) | CP.PHAR.226 | May 1, 2016 |
Fosdenopterin (Nulibry) (PDF) | CP.PHAR.471 | June 1, 2020 |
Fostamatinib (Tavalisse) (PDF) | CP.PHAR.24 | June 5, 2018 |
Fostemsavir (Rukobia) (PDF) | CP.PHAR.516 | March 1, 2021 |
Fremanezumab-vfrm (Ajovy) (PDF) | HIM.PA.SP66 | October 1, 2020 |
Fulvestrant (Faslodex Injection) (PDF) | CP.PHAR.424 | September 1, 2019 |
Gabapentin ER (Gralise, Horizant) (PDF) | CP.PMN.240 | September 1, 2020 |
Galcanezumab-gnlm (Emgality) (PDF) | HIM.PA.SP67 | October 1, 2020 |
Galsulfase (Naglazyme) (PDF) | CP.PHAR.161 | February 1, 2016 |
Ganaxolone (Ztalmy) (PDF) | CP.PMN.278 | June 1, 2022 |
Gefitinib (Iressa) (PDF) | CP.PHAR.68 | November 16, 2016 |
Gemtuzumab Ozogamicin (Mylotarg) (PDF) | CP.PHAR.358 | October 3, 2017 |
Gilteritinib (Xospata) (PDF) | CP.PHAR.412 | January 15, 2019 |
Givosiran (Givlaari) (PDF) | CP.PHAR.457 | March 1, 2020 |
Glasdegib (Daurismo) (PDF) | CP.PHAR.413 | January 8, 2019 |
Glatiramer Acetate (Copaxone, Glatopa) (PDF) | HIM.PA.SP68 | March 1, 2021 |
Glecaprevir/Pibrentasvir (Mavyret) (PDF) | HIM.PA.SP36 | August 31, 2019 |
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (PDF) | HIM.PA.53 | March 1, 2018 |
Glycerol Phenylbutyrate (Ravicti) (PDF) | CP.PHAR.207 | April 30, 2016 |
Golodirsen (Vyondys 53) (PDF) | CP.PHAR.453 | March 1, 2020 |
Goserelin Acetate (Zoladex) (PDF) | CP.PHAR.171 | November 9, 2017 |
Granisetron (Sancuso, Sustol) (PDF) | CP.PMN.74 | November 1, 2016 |
Halcinonide (Halog) (PDF) | HIM.PA.20 | August 28, 2018 |
Halobetasol Propionate (Bryhali, Lexette, Ultravate) (PDF) | CP.PMN.180 | December 1, 2018 |
Halobetasol Propionate/Tazarotene (Duobrii) (PDF) | CP.PMN.208 | September 1, 2019 |
Hemin (Panhematin) (PDF) | CP.PHAR.181 | February 1, 2016 |
Histrelin Acetate (Vantas, Supprelin LA) (PDF) | CP.PHAR.172 | November 9, 2017 |
House Dust Mite Allergen Extract (Odactra) (PDF) | CP.PMN.111 | August 31, 2017 |
Human Growth Hormone (Somapacitan, Somatropin) (PDF) | HIM.PA.161 | January 1, 2022 |
Hyaluronate Derivatives (PDF) | CP.PHAR.05 | October 1, 2008 |
Hydroxyprogesterone Caproate (Makena/compound) (PDF) | CP.PHAR.14 | November 20, 2017 |
Hydroxyurea (Siklos) (PDF) | CP.PMN.193 | February 19, 2019 |
Ibalizumab-uiyk (Trogarzo) (PDF) | CP.PHAR.378 | April 17, 2018 |
Ibandronate Injection (Boniva) (PDF) | CP.PHAR.189 | November 15, 2017 |
Ibrutinib (Imbruvica) (PDF) | CP.PHAR.126 | October 1, 2015 |
Ibuprofen/Famotidine (Duexis) (PDF) | CP.PMN.120 | June 1, 2018 |
Icatibant (Firazyr) (PDF) | CP.PHAR.178 | March 1, 2016 |
Icosapent Ethyl (Vascepa) (PDF) | CP.PMN.187 | November 20, 2018 |
Idecabtagene Vicleucel (Abecma) (PDF) | CP.PHAR.481 | June 1, 2020 |
Idelalisib (Zydelig) (PDF) | CP.PHAR.133 | December 1, 2018 |
Idursulfase (Elaprase) (PDF) | CP.PHAR.156 | February 1, 2016 |
Iloperidone (Fanapt) (PDF) | CP.PMN.32 | December 1, 2014 |
Iloprost (Ventavis) (PDF) | CP.PHAR.193 | March 1, 2016 |
Imatinib (Gleevec) (PDF) | CP.PHAR.65 | June 1, 2011 |
Imiglucerase (Cerezyme) (PDF) | CP.PHAR.154 | February 1, 2016 |
Immune Globulins (PDF) | CP.PHAR.103 | August 1, 2012 |
Inclisiran (Leqvio) (PDF) | CP.PHAR.568 | March 1, 2022 |
IncobotulinumtoxinA (Xeomin) (PDF) | CP.PHAR.231 | July 1, 2016 |
Inebilizumab-cdon (Uplizna) (PDF) | CP.PHAR.458 | March 1, 2020 |
Infertility and Fertility Preservation (PDF) | CP.PHAR.131 | November 16, 2016 |
Infigratinib (Truseltiq) (PDF) | CP.PHAR.547 | September 1, 2021 |
Inhaled Agents for Asthma and COPD (PDF) | HIM.PA.153 | March 1, 2021 |
Inotersen (Tegsedi) (PDF) | CP.PHAR.405 | November 20, 2018 |
Inotuzumab Ozogamicin (Besponsa) (PDF) | CP.PHAR.359 | September 26, 2017 |
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF) | CP.PHAR.534 | June 1, 2021 |
Insulin Glargine (Rezvoglar, Semglee, Toujeo) (PDF) | HIM.PA.09 | March 1, 2019 |
Interferon Beta-1a (Avonex, Rebif) (PDF) | CP.PHAR.255 | August 1, 2016 |
Interferon Beta-1b (Betaseron, Extavia) (PDF) | CP.PCH.46 | March 1, 2022 |
Interferon Gamma- 1b (Actimmune) (PDF) | CP.PHAR.52 | June 1, 2010 |
Iobenguane I-131 (Azedra) (PDF) | CP.PHAR.459 | March 1, 2020 |
Ipilimumab (Yervoy) (PDF) | CP.PHAR.319 | April 17, 2018 |
Irinotecan Liposome (Onivyde) (PDF) | CP.PHAR.304 | February 1, 2017 |
Iron Sucrose (Venofer) (PDF) | CP.PHAR.167 | March 1, 2016 |
Isatuximab-irfc (Sarclisa) (PDF) | CP.PHAR.482 | June 1, 2020 |
Isavuconazonium (Cresemba) (PDF) | CP.PMN.154 | November 16, 2016 |
Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) (PDF) | CP.PMN.143 | December 1, 2014 |
Istradefylline (Nourianz) (PDF) | CP.PMN.217 | March 1, 2020 |
Itraconazole (Sporanox, Tolsura) (PDF) | CP.PMN.124 | November 1, 2006 |
Ivabradine (Corlanor) (PDF) | CP.PMN.70 | November 1, 2015 |
Ivacaftor (Kalydeco) (PDF) | CP.PHAR.210 | May 1, 2016 |
Ivermectin (Stromectol, Sklice) (PDF) | CP.PMN.269 | December 1, 2021 |
Ivosidenib (Tibsovo) (PDF) | CP.PHAR.137 | August 21, 2018 |
Ixazomib (Ninlaro) (PDF) | CP.PHAR.302 | February 1, 2017 |
Ketorolac Nasal Spray (Sprix) (PDF) | CP.PMN.282 | December 1, 2022 |
Lanadelumab-fylo (Takhzyro) (PDF) | CP.PHAR.396 | September 25, 2018 |
Lanreotide (Somatuline Depot) (PDF) | CP.PHAR.391 | August 14, 2018 |
Lapatinib (Tykerb) (PDF) | CP.PHAR.79 | November 9, 2017 |
Laronidase (Aldurazyme) (PDF) | CP.PHAR.152 | February 1, 2016 |
Larotrectinib (Vitrakvi) (PDF) | CP.PHAR.414 | January 15, 2018 |
Lasmiditan (Reyvow) (PDF) | CP.PMN.218 | March 1, 2020 |
Latanoprostene Bunod (Vyzulta) (PDF) | CP.PMN.108 | March 1, 2018 |
Ledipasvir/Sofosbuvir (Harvoni) (PDF) | HIM.PA.SP3 | August 31, 2016 |
Lefamulin (Xenleta) (PDF) | CP.PMN.219 | March 1, 2020 |
Lenalidomide (Revlimid) (PDF) | CP.PHAR.71 | July 1, 2011 |
Lenvatinib (Lenvima) (PDF) | CP.PHAR.138 | December 1, 2018 |
Letermovir (Prevymis) (PDF) | CP.PHAR.367 | March 1, 2018 |
Leucovorin Injection (PDF) | CP.PHAR.393 | December 1, 2018 |
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) | CP.PHAR.173 | November 9, 2017 |
Levodopa Inhalation Powder (Inbrija) (PDF) | CP.PMN.267 | December 1, 2021 |
Levoketoconazole (Recorlev) (PDF) | CP.PMN.275 | June 1, 2022 |
Levoleucovorin (Fusilev, Khapzory) (PDF) | CP.PHAR.151 | November 9, 2017 |
Levomilnacipran (Fetzima) (PDF) | HIM.PA.125 | November 9, 2017 |
L-glutamine (Endari) (PDF) | CP.PMN.116 | November 9, 2017 |
Lidocaine Transdermal (Lidoderm, ZTlido) (PDF) | CP.PMN.08 | September 1, 2006 |
Lifitegrast (Xiidra) (PDF) | CP.PMN.73 | November 9, 2017 |
Linaclotide (Linzess) (PDF) | CP.PMN.71 | November 1, 2015 |
Linezolid (Zyvox) (PDF) | CP.PMN.27 | September 1, 2016 |
Lisocabtagene Maraleucel (Breyanzi) (PDF) | CP.PHAR.483 | June 1, 2020 |
Lofexidine (Lucemyra) (PDF) | CP.PMN.152 | August 1, 2018 |
Lomustine (Gleostine) (PDF) | CP.PHAR.507 | December 1, 2020 |
Lonafarnib (Zokinvy) (PDF) | CP.PHAR.499 | September 1, 2020 |
Loncastuximab Tesirine-lpyl (Zynlonta) (PDF) | CP.PHAR.539 | September 1, 2021 |
Lorlatinib (Lorbrena) (PDF) | CP.PHAR.406 | December 11, 2018 |
Loteprednol etabonate (Eysuvis) (PDF) | CP.PMN.260 | March 1, 2021 |
Lubiprostone (Amitiza) (PDF) | CP.PMN.142 | December 1, 2014 |
Luliconazole Cream (Luzu) (PDF) | CP.PMN.166 | August 28, 2018 |
Lumacaftor/Ivacaftor (Orkambi) (PDF) | CP.PHAR.213 | May 1, 2016 |
Lumasiran (Oxlumo) (PDF) | CP.PHAR.473 | June 1, 2020 |
Lumateperone (Caplyta) (PDF) | CP.PMN.232 | March 1, 2020 |
Lurasidone (Latuda) (PDF) | CP.PMN.50 | December 1, 2014 |
Lurbinectedin (Zepzelca) (PDF) | CP.PHAR.500 | September 1, 2020 |
Luspatercept-aamt (Reblozyl) (PDF) | CP.PHAR.450 | March 1, 2020 |
Lusutrombopag (Mulpleta) (PDF) | CP.PHAR.407 | September 18, 2018 |
Lutetium Lu 177 Dotatate (Lutathera) (PDF) | CP.PHAR.384 | May 22, 2018 |
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF) | CP.PHAR.582 | June 1, 2022 |
Macitentan (Opsumit) (PDF) | CP.PHAR.194 | March 1, 2016 |
Mannitol (Bronchitol) (PDF) | CP.PHAR.518 | March 1, 2021 |
Maralixibat (Livmarli) (PDF) | CP.PHAR.543 | September 1, 2021 |
Margetuximab-cmkb (Margenza) (PDF) | CP.PHAR.522 | March 1, 2021 |
Maribavir (Livtencity) (PDF) | CP.PMN.271 | March 1, 2022 |
Mavacamten (Camzyos) (PDF) | CP.PMN.272 | March 1, 2022 |
Mecamylamine (Vecamyl) (PDF) | CP.PMN.136 | May 1, 2017 |
Mecasermin (Increlex) (PDF) | CP.PHAR.150 | March 1, 2011 |
Mechlorethamine Gel (Valchlor) (PDF) | CP.PHAR.381 | November 16, 2016 |
Megestrol Acetate (Megace ES) (PDF) | CP.PMN.179 | December 1, 2018 |
Melphalan flufenamide (Pepaxto) (PDF) | CP.PHAR.535 | June 1, 2021 |
Memantine ER (Namenda XR), Memantine/Donepezil (Namzaric) (PDF) | CP.PCH.30 | September 1, 2020 |
Mepolizumab (Nucala) (PDF) | CP.PHAR.200 | April 1, 2016 |
Mercaptopurine (Purixan) (PDF) | CP.PHAR.447 | March 1, 2020 |
Metformin ER (Fortamet, Glumetza) (PDF) | CP.PMN.72 | October 31, 2015 |
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF) | CP.PHAR.134 | December 1, 2018 |
Methoxsalen (Uvadex) (PDF) | HIM.PA.17 | September 4, 2018 |
Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) (PDF) | CP.PHAR.238 | June 1, 2016 |
Methylnaltrexone Bromide (Relistor) (PDF) | CP.PMN.169 | December 1, 2018 |
Metoclopramide (Gimoti) (PDF) | CP.PMN.252 | December 1, 2020 |
Metreleptin (Myalept) (PDF) | CP.PHAR.425 | September 1, 2019 |
Midazolam (Nayzilam) (PDF) | CP.PMN.211 | September 1, 2019 |
Midostaurin (Rydapt) (PDF) | CP.PHAR.344 | June 1, 2017 |
Mifepristone (Korlym) (PDF) | CP.PHAR.101 | May 1, 2012 |
Migalastat (Galafold) (PDF) | CP.PHAR.394 | September 11, 2018 |
Miglustat (Zavesca) (PDF) | CP.PHAR.164 | February 1, 2016 |
Milnacipran (Savella) (PDF) | CP.PMN.125 | August 1, 2012 |
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) | CP.PMN.80 | April 30, 2017 |
Mitapivat (Pyrukynd) (PDF) | CP.PHAR.558 | December 1, 2021 |
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) | CP.PHAR.495 | September 1, 2020 |
Mitoxantrone (PDF) | CP.PHAR.258 | August 1, 2016 |
Mobocertinib (Exkivity) (PDF) | CP.PHAR.559 | December 1, 2021 |
Modafinil (Provigil) (PDF) | CP.PMN.39 | May 1, 2008 |
Mogamulizumab-kpkc (Poteligeo) (PDF) | CP.PHAR.139 | September 4, 2018 |
Mometasone (Nasonex) (PDF) | HIM.PA.93 | December 1, 2014 |
Mometasone Furoate (Sinuva) (PDF) | CP.PHAR.448 | March 1, 2020 |
Montelukast Oral Granules (Singulair) (PDF) | HIM.PA.129 | November 9, 2017 |
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) | CP.PHAR.398 | October 16, 2018 |
Nafarelin Acetate (Synarel) (PDF) | CP.PHAR.174 | November 9, 2017 |
Naltrexone (Vivitrol) (PDF) | CP.PHAR.96 | March 1, 2012 |
Naproxen Oral Suspension (Naprosyn) (PDF) | HIM.PA.130 | November 9, 2017 |
Naproxen/Esomeprazole (Vimovo) (PDF) | CP.PMN.117 | June 1, 2018 |
Natalizumab (Tysabri) (PDF) | CP.PHAR.259 | July 1, 2016 |
Naxitamab-gqgk (Danyelza) (PDF) | CP.PHAR.523 | March 1, 2021 |
Necitumumab (Portrazza) (PDF) | CP.PHAR.320 | March 1, 2017 |
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) | CP.PMN.167 | August 28, 2018 |
Neratinib (Nerlynx) (PDF) | CP.PHAR.365 | September 5, 2017 |
Netarsudil (Rhopressa), Netarsudil/Latanoprost (Rocklatan) (PDF) | CP.PMN.118 | February 13, 2018 |
Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) (PDF) | CP.PMN.158 | September 1, 2006 |
Nifurtimox (Lampit) (PDF) | CP.PMN.256 | December 1, 2020 |
Nilotinib (Tasigna) (PDF) | CP.PHAR.76 | September 1, 2011 |
Nintedanib (Ofev) (PDF) | CP.PHAR.285 | October 1, 2016 |
Niraparib (Zejula) (PDF) | CP.PHAR.408 | May 9, 2017 |
Nitazoxanide (Alinia) (PDF) | HIM.PA.152 | December 1, 2020 |
Nitisinone (Nityr, Orfadin) (PDF) | CP.PHAR.132 | August 28, 2018 |
Nivolumab (Opdivo) (PDF) | CP.PHAR.121 | July 1, 2015 |
Nivolumab and Relatlimab-rmbw (Opdualag) (PDF) | CP.PHAR.588 | September 1, 2022 |
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) | HIM.PA.33 | May 1, 2016 |
Non-Calcium Phosphate Binders (PDF) | CP.PMN.04 | November 15, 2017 |
Non-Formulary and Formulary Contraceptives (PDF) | HIM.PA.100 | May 1, 2015 |
Non-Formulary Test Strips (PDF) | HIM.PA.34 | February 1, 2016 |
Nusinersen (Spinraza) (PDF) | CP.PHAR.327 | November 28, 2017 |
Obeticholic Acid (Ocaliva) (PDF) | CP.PHAR.287 | November 1, 2016 |
Obinutuzumab (Gazyva) (PDF) | CP.PHAR.305 | February 1, 2017 |
Ocrelizumab (Ocrevus) (PDF) | CP.PHAR.335 | April 1, 2017 |
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF) | CP.PHAR.40 | March 1, 2010 |
Odevixibat (Bylvay) (PDF) | CP.PHAR.528 | June 1, 2021 |
Ofatumumab (Arzerra, Kesimpta) (PDF) | CP.PHAR.306 | February 1, 2017 |
Off-Label Drug Use (PDF) | HIM.PA.154 | February 1, 2021 |
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) | CP.PHAR.292 | December 1, 2016 |
Olanzapine/Samidorphan (Lybalvi) (PDF) | CP.PMN.265 | September 1, 2021 |
Olaparib (Lynparza) (PDF) | CP.PHAR.360 | October 3, 2017 |
Olaratumab (Lartruvo) (PDF) | CP.PHAR.326 | March 1, 2017 |
Olipudase Alfa-rpcp (Xenpozyme) (PDF) | CP.PHAR.586 | June 2, 2022 |
Omacetaxine (Synribo) (PDF) | CP.PHAR.108 | April 1, 2013 |
Omadacycline (Nuzyra) (PDF) | CP.PMN.188 | November 20, 2018 |
Omalizumab (Xolair) (PDF) | CP.PHAR.01 | October 1, 2008 |
OnabotulinumtoxinA (Botox) (PDF) | CP.PHAR.232 | July 1, 2016 |
Onasemnogene Abeparvovec (Zolgensma) (PDF) | CP.PHAR.421 | June 7, 2019 |
Ondansetron (Zuplenz) (PDF) | CP.PMN.45 | September 1, 2006 |
Ophthalmic Corticosteroids (PDF) | HIM.PA.03 | January 1, 2020 |
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) | CP.PHAR.536 | June 1, 2021 |
Opicapone (Ongentys) (PDF) | CP.PMN.245 | September 1, 2020 |
Opioid Analgesics* (PDF) | HIM.PA.139 | August 1, 2018 |
Osilodrostat (Isturisa) (PDF) | CP.PHAR.487 | September 1, 2020 |
Osimertinib (Tagrisso) (PDF) | CP.PHAR.294 | December 1, 2016 |
Ospemifene (Osphena) (PDF) | CP.PMN.168 | August 28, 2018 |
Overactive Bladder Agents (PDF) | CP.PMN.198 | May 1, 2016 |
Oxymetazoline (Rhofade, Upneeq) (PDF) | CP.PMN.86 | November 15, 2016 |
Ozanimod (Zeposia) (PDF) | CP.PHAR.462 | March 1, 2020 |
Ozenoxacin (Xepi) (PDF) | CP.PMN.119 | January 30, 2018 |
Paclitaxel, Protein-Bound (Abraxane) (PDF) | CP.PHAR.176 | July 1, 2015 |
Pacritinib (Vonjo) (PDF) | CP.PHAR.583 | June 1, 2022 |
Palbociclib (Ibrance) (PDF) | CP.PHAR.125 | October 1, 2015 |
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF) | CP.PHAR.291 | December 1, 2016 |
Palivizumab (Synagis) (PDF) | CP.PHAR.16 | July 31, 2009 |
Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) | CP.PCH.44 | March 1, 2022 |
Panitumumab (Vectibix) (PDF) | CP.PHAR.321 | March 1, 2017 |
Panobinostat (Farydak) (PDF) | CP.PHAR.382 | November 16, 2016 |
Parathyroid Hormone (Natpara) (PDF) | CP.PHAR.282 | November 16, 2016 |
Paricalcitol Injection (Zemplar) (PDF) | CP.PHAR.270 | August 1, 2016 |
Pasireotide (Signifor, Signifor LAR) (PDF) | CP.PHAR.332 | March 1, 2017 |
Patiromer (Veltassa) (PDF) | CP.PMN.205 | September 1, 2019 |
Patisiran (Onpattro) (PDF) | CP.PHAR.395 | September 11, 2018 |
Pazopanib (Votrient) (PDF) | CP.PHAR.81 | October 1, 2011 |
Peanut Allergen Powder-dnfp (Palforzia) (PDF) | CP.PMN.220 | March 1, 2020 |
Pegaptanib (Macugen) (PDF) | CP.PHAR.185 | March 1, 2016 |
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) | CP.PHAR.353 | September 5, 2017 |
Pegcetacoplan (Empaveli, APL-2) (PDF) | CP.PHAR.524 | March 1, 2021 |
Pegfilgrastim (Neulasta, Neulasta Onpro), Pegfilgrastim-jmdb (Fulphila), Pegfilgrastim-pbbk (Fylnetra), Pegfilgrastim-apgf (Nyvepria), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim-fpgk (Stimufend), Pegfilgrastim-cbqv (Udenyca), Pegfilgrastim-bmez (Ziexten) (PDF) | CP.PHAR.296 | December 1, 2016 |
Peginterferon Alfa-2a,b (Pegasys, PegIntron) (PDF) | CP.PHAR.89 | October 1, 2011 |
Peginterferon Beta-1a (Plegridy) (PDF) | CP.PHAR.271 | August 1, 2016 |
Pegloticase (Krystexxa) (PDF) | CP.PHAR.115 | June 1, 2013 |
Pegvaliase-pqpz (Palynziq) (PDF) | CP.PHAR.140 | July 31, 2018 |
Pegvisomant (Somavert) (PDF) | CP.PHAR.389 | December 1, 2018 |
Pembrolizumab (Keytruda) (PDF) | CP.PHAR.322 | March 1, 2017 |
Pemetrexed (Alimta, Pemfexy) (PDF) | CP.PHAR.368 | October 31, 2017 |
Pemigatinib (Pemazyre) (PDF) | CP.PHAR.496 | September 1, 2020 |
Penicillamine (Cuprimine) (PDF) | CP.PCH.09 | December 1, 2018 |
Perampanel (Fycompa) (PDF) | CP.PMN.156 | November 16, 2016 |
Pertuzumab (Perjeta) (PDF) | CP.PHAR.227 | June 1, 2016 |
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF) | CP.PHAR.501 | September 1, 2020 |
Pexidartinib (Turalio) (PDF) | CP.PHAR.436 | December 1, 2019 |
Phendimetrazine (PDF) | CP.PCH.47 | June 1, 2022 |
Phentermine (Adipex-P, Lomaira) (PDF) | CP.PCH.13 | May 1, 2017 |
Pilocarpine (Vuity) (PDF) | CP.PMN.270 | December 1, 2021 |
Pimavanserin (Nuplazid) (PDF) | CP.PMN.140 | November 16, 2016 |
Pirfenidone (Esbriet) (PDF) | CP.PHAR.286 | October 1, 2016 |
Pitolisant (Wakix) (PDF) | CP.PMN.221 | March 1, 2020 |
Plasminogen, Human-tvmh (Ryplazim) (PDF) | CP.PHAR.513 | June 3, 2021 |
Plecanatide (Trulance) (PDF) | HIM.PA.158 | June 1, 2021 |
Plerixafor (Mozobil) (PDF) | CP.PHAR.323 | March 1, 2017 |
Polatuzumab Vedotin-piiq (Polivy) (PDF) | CP.PHAR.433 | September 1, 2019 |
Pomalidomide (Pomalyst) (PDF) | CP.PHAR.116 | July 1, 2013 |
Ponatinib (Iclusig) (PDF) | CP.PHAR.112 | June 1, 2013 |
Ponesimod (Ponvory) (PDF) | CP.PHAR.537 | June 1, 2021 |
Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF) | HIM.PA.143 | October 31, 2017 |
Pralatrexate (Folotyn) (PDF) | CP.PHAR.313 | February 1, 2017 |
Pramlintide (Symlin) (PDF) | CP.PMN.129 | June 1, 2018 |
Prasterone (Intrarosa) (PDF) | CP.PMN.99 | December 20, 2016 |
Pregabalin (Lyrica, Lyrica CR) (PDF) | CP.PMN.33 | January 1, 2007 |
Pretomanid (PDF) | CP.PMN.222 | March 1, 2020 |
Progesterone (Crinone, Endometrin, Milprosa) (PDF) | CP.PMN.243 | September 1, 2020 |
Propranolol HCl Oral Solution (Hemangeol) (PDF) | CP.PMN.58 | May 1, 2014 |
Protein C Concentrate, Human (Ceprotin) (PDF) | CP.PHAR.330 | March 1, 2017 |
Prucalopride (Motegrity) (PDF) | HIM.PA.159 | June 1, 2021 |
Pyrimethamine (Daraprim) (PDF) | CP.PMN.44 | November 1, 2015 |
Quetiapine Extended-Release (Seroquel XR) (PDF) | CP.PMN.64 | December 1, 2014 |
Quinine Sulfate (Qualaquin) (PDF) | CP.PMN.262 | June 1, 2021 |
Ramucirumab (Cyramza) (PDF) | CP.PHAR.119 | May 1, 2015 |
Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF) | CP.PHAR.186 | April 1, 2016 |
Rasagiline (Azilect) (PDF) | HIM.PA.89 | December 1, 2014 |
Ravulizumab-cwvz (Ultomiris) (PDF) | CP.PHAR.415 | February 19, 2019 |
Regorafenib (Stivarga) (PDF) | CP.PHAR.107 | December 1, 2012 |
Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF) | CP.PHAR.529 | June 1, 2021 |
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF) | CP.PHAR.168 | March 1, 2016 |
Reslizumab (Cinqair) (PDF) | CP.PHAR.223 | May 1, 2016 |
Ribavirin (Rebetol, Ribasphere) (PDF) | CP.PHAR.141 | November 16, 2016 |
Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) (PDF) | CP.PHAR.334 | May 1, 2017 |
Rifabutin (Mycobutin) (PDF) | CP.PMN.223 | March 1, 2020 |
Rifamycin (Aemcolo) (PDF) | CP.PMN.196 | January 8, 2019 |
Rifaximin (Xifaxan) (PDF) | CP.PMN.47 | November 1, 2011 |
Rilonacept (Arcalyst) (PDF) | CP.PHAR.266 | November 16, 2016 |
RimabotulinumtoxinB (Myobloc) (PDF) | CP.PHAR.233 | July 1, 2016 |
Rimegepant (Nurtec ODT) (PDF) | CP.PHAR.490 | September 1, 2020 |
Riociguat (Adempas) (PDF) | CP.PHAR.195 | March 1, 2016 |
Ripretinib (Qinlock) (PDF) | CP.PHAR.502 | September 1, 2020 |
Risdiplam (Evrysdi) (PDF) | CP.PHAR.477 | August 6, 2020 |
Risedronate (Actonel, Atelvia) (PDF) | CP.PMN.100 | March 1, 2018 |
Risperidone Long-Acting Injection (Perseris, Risperdal Consta) (PDF) | CP.PHAR.293 | December 1, 2016 |
Rolapitant (Varubi) (PDF) | CP.PMN.102 | February 1, 2017 |
Romidepsin (Istodax) (PDF) | CP.PHAR.314 | January 1, 2017 |
Romiplostim (Nplate) (PDF) | CP.PHAR.179 | March 1, 2016 |
Romosozumab-aqqg (Evenity) (PDF) | CP.PHAR.428 | September 1, 2019 |
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF) | CP.PHAR.570 | March 1, 2022 |
Rucaparib (Rubraca) (PDF) | CP.PHAR.350 | September 1, 2017 |
Rufinamide (Banzel) (PDF) | CP.PMN.157 | December 1, 2014 |
Ruxolitinib (Jakafi, Opzelura) (PDF) | CP.PHAR.98 | March 1, 2012 |
Sacituzumab Govitecan-hziy (Trodelvy) (PDF) | CP.PHAR.475 | June 1, 2020 |
Sacituzumab Govitecan-hziy (Trodelvy) (PDF) | CP.PHAR.475 | June 1, 2020 |
Sacubitril/Valsartan (Entresto) (PDF) | CP.PMN.67 | November 1, 2015 |
Safinamide (Xadago) (PDF) | CP.PMN.113 | July 1, 2017 |
Sapropterin Dihydrochloride (Kuvan) (PDF) | CP.PHAR.43 | February 1, 2010 |
Sarecycline (Seysara) (PDF) | CP.PMN.189 | November 13, 2018 |
Sargramostim (Leukine) (PDF) | CP.PHAR.295 | December 1, 2016 |
Satralizumab-mwge (Enspryng) (PDF) | CP.PHAR.463 | March 1, 2020 |
Sebelipase Alfa (Kanuma) (PDF) | CP.PHAR.159 | February 1, 2016 |
Secnidazole (Solosec) (PDF) | CP.PMN.103 | October 24, 2017 |
Selexipag (Uptravi) (PDF) | CP.PHAR.196 | March 1, 2016 |
Selinexor (Xpovio) (PDF) | CP.PHAR.431 | September 1, 2019 |
Selpercatinib (Retevmo) (PDF) | CP.PHAR.478 | June 1, 2020 |
Selumetinib (Koselugo) (PDF) | CP.PHAR.464 | March 1, 2020 |
Setmelanotide (Imcivree) (PDF) | CP.PHAR.491 | September 1, 2020 |
Short Ragweed Pollen Allergen Extract (Ragwitek) (PDF) | CP.PMN.83 | August 31, 2017 |
Sildenafil (Revatio) (PDF) | CP.PHAR.197 | March 1, 2016 |
Sildenafil for ED (Viagra) (PDF) | CP.PCH.07 | June 1, 2018 |
Siltuximab (Sylvant) (PDF) | CP.PHAR.329 | March 1, 2017 |
Siponimod (Mayzent) (PDF) | CP.PHAR.427 | September 1, 2019 |
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF) | CP.PHAR.574 | March 1, 2022 |
Sodium Oxybate (Xyrem) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (PDF) | CP.PMN.42 | May 1, 2011 |
Sodium Phenylbutyrate (Buphenyl, Pheburane) (PDF) | CP.PHAR.208 | May 1, 2016 |
Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (PDF) | CP.PHAR.584 | June 1, 2022 |
Sodium Zirconium Cyclosilicate (Lokelma) (PDF) | CP.PMN.163 | July 24, 2018 |
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (PDF) | HIM.PA.91 | January 1, 2015 |
Sofosbuvir (Sovaldi) (PDF) | HIM.PA.SP2 | August 31, 2016 |
Sofosbuvir/Velpatasvir (Epclusa) (PDF) | HIM.PA.SP1 | August 31, 2016 |
Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (PDF) | HIM.PA.SP63 | August 1, 2020 |
Solriamfetol (Sunosi) (PDF) | CP.PMN.209 | September 1, 2019 |
Sonidegib (Odomzo) (PDF) | CP.PHAR.272 | May 1, 2012 |
Sorafenib (Nexavar) (PDF) | CP.PHAR.69 | July 1, 2011 |
Spinosad (Natroba) (PDF) | HIM.PA.134 | November 9, 2017 |
Step Therapy (PDF) | HIM.PA.109 | August 1, 2017 |
Stiripentol (Diacomit) (PDF) | CP.PMN.184 | September 25, 2018 |
Sunitinib (Sutent) (PDF) | CP.PHAR.73 | September 1, 2011 |
Sutimlimab-jome (Enjaymo) (PDF) | CP.PHAR.503 | February 3, 2022 |
Suvorexant (Belsomra) (PDF) | CP.PMN.109 | February 1, 2017 |
Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) (PDF) | CP.PMN.85 | August 31, 2017 |
Tadalafil (Adcirca, Alyq, Tadliq) (PDF) | CP.PHAR.198 | March 1, 2016 |
Tadalafil BPH - ED (Cialis) (PDF) | CP.PMN.132 | June 1, 2018 |
Tafamidis (Vyndaqel, Vyndamax) (PDF) | CP.PHAR.432 | September 1, 2019 |
Tafasitamab-cxix (Monjuvi) (PDF) | CP.PHAR.508 | December 1, 2020 |
Talazoparib (Talzenna) (PDF) | CP.PHAR.409 | November 27, 2018 |
Taliglucerase Alfa (Elelyso) (PDF) | HIM.PA.162 | January 1, 2022 |
Talimogene laherepvec (Imlygic) (PDF) | CP.PHAR.542 | September 1, 2021 |
Tapinarof (Vtama) (PDF) | CP.PMN.283 | December 1, 2022 |
Tasimelteon (Hetlioz, Hetlioz LQ) (PDF) | CP.PMN.104 | February 1, 2017 |
Tavaborole (Kerydin) (PDF) | CP.PMN.105 | March 1, 2018 |
Tazarotene (Arazlo, Fabior, Tazorac) (PDF) | CP.PMN.244 | September 1, 2020 |
Tazemetostat (Tazverik) (PDF) | CP.PHAR.452 | March 1, 2020 |
Tebentafusp-tebn (Kimmtrak) (PDF) | CP.PHAR.575 | June 1, 2022 |
Tedizolid (Sivextro) (PDF) | CP.PMN.62 | March 1, 2015 |
Teduglutide (Gattex) (PDF) | CP.PHAR.114 | May 1, 2013 |
Tegaserod (Zelnorm) (PDF) | HIM.PA.160 | June 1, 2021 |
Telotristat Ethyl (Xermelo) (PDF) | CP.PHAR.337 | June 1, 2017 |
Temozolomide (Temodar) (PDF) | CP.PHAR.77 | September 1, 2011 |
Temsirolimus (Torisel) (PDF) | CP.PHAR.324 | March 1, 2017 |
Tenapanor (Ibsrela) (PDF) | CP.PMN.224 | March 1, 2020 |
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) | CP.PMN.268 | December 1, 2021 |
Tepotinib (Tepmetko) (PDF) | CP.PHAR.530 | June 1, 2021 |
Teprotumumab (Tepezza) (PDF) | CP.PHAR.465 | January 21, 2020 |
Teriflunomide (Aubagio) (PDF) | CP.PCH.40 | February 1, 2021 |
Teriparatide (Forteo) (PDF) | CP.PHAR.188 | November 15, 2017 |
Tesamorelin (Egrifta SV) (PDF) | CP.PHAR.109 | March 1, 2014 |
Testosterone (Androderm) (PDF) | HIM.PA.87 | December 1, 2014 |
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) | CP.PHAR.354 | August 1, 2017 |
Tetrabenazine (Xenazine) (PDF) | CP.PHAR.92 | December 1, 2011 |
Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) (PDF) | CP.PHAR.377 | April 3, 2018 |
Tezepelumab-ekko (Tezspire) (PDF) | CP.PHAR.576 | June 1, 2022 |
Thalidomide (Thalomid) (PDF) | CP.PHAR.78 | September 1, 2011 |
Thioguanine (Tabloid) (PDF) | CP.PHAR.437 | December 1, 2019 |
Thyrotropin Alfa (Thyrogen) (PDF) | CP.PHAR.95 | March 1, 2012 |
Timothy Grass Pollen Allergen Extract (Grastek) (PDF) | CP.PMN.84 | August 31, 2017 |
Tisagenlecleucel (Kymriah) (PDF) | CP.PHAR.361 | September 26, 2017 |
Tisotumab Vedotin-tftv (Tivdak) (PDF) | CP.PHAR.561 | December 1, 2021 |
Tivozanib (Fotivda) (PDF) | CP.PHAR.538 | June 1, 2021 |
Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (PDF) | CP.PHAR.211 | May 1, 2016 |
Tolvaptan (Jynarque, Samsca) (PDF) | CP.PHAR.27 | June 5, 2018 |
Topical Acne Treatment (PDF) | HIM.PA.71 | December 1, 2014 |
Topical Immunomodulators (PDF) | CP.PMN.107 | September 1, 2006 |
Topiramate Extended-Release (Qudexy XR, Trokendi XR) (PDF) | CP.PMN.281 | September 1, 2022 |
Topotecan (Hycamtin) (PDF) | CP.PHAR.64 | June 1, 2011 |
Trabectedin (Yondelis) (PDF) | CP.PHAR.204 | May 1, 2016 |
Tralokinumab-ldrm (Adbry) (PDF) | CP.PHAR.577 | June 1, 2022 |
Trametinib (Mekinist) (PDF) | CP.PHAR.240 | July 1, 2016 |
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF) | CP.PHAR.228 | June 1, 2016 |
Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) (PDF) | CP.PHAR.199 | March 1, 2016 |
Triamcinolone ER Injection (Zilretta) (PDF) | CP.PHAR.371 | March 1, 2018 |
Triclabendazole (Egaten) (PDF) | CP.PMN.207 | September 1, 2019 |
Trientine (Cuvrior, Syprine) (PDF) | CP.PHAR.438 | December 1, 2019 |
Trifarotene (Aklief) (PDF) | CP.PMN.225 | March 1, 2020 |
Trifluridine/Tipiracil (Lonsurf) (PDF) | CP.PHAR.383 | November 16, 2016 |
Triheptanoin (Dojolvi) (PDF) | CP.PHAR.509 | December 1, 2020 |
Triptorelin Pamoate (Trelstar, Triptodur) (PDF) | CP.PHAR.175 | November 9, 2017 |
Tucatinib (Tukysa) (PDF) | CP.PHAR.497 | September 1, 2020 |
Ubrogepant (Ubrelvy) (PDF) | CP.PHAR.476 | June 1, 2020 |
Ulcer Therapy Combinations (PDF) | CP.PMN.277 | June 1, 2022 |
Umbralisib (Ukoniq) (PDF) | CP.PHAR.531 | June 1, 2021 |
Uridine Triacetate (Vistogard) (PDF) | HIM.PA.SP55 | November 9, 2017 |
Valbenazine (Ingrezza) (PDF) | CP.PCH.48 | September 1, 2022 |
Valganciclovir (Valcyte) (PDF) | CP.PCH.06 | November 16, 2016 |
Valrubicin (Valstar) (PDF) | CP.PHAR.439 | December 1, 2019 |
Vandetanib (Caprelsa) (PDF) | CP.PHAR.80 | October 1, 2011 |
Varenicline (Tyrvaya) (PDF) | CP.PMN.273 | March 1, 2022 |
Velaglucerase Alfa (VPRIV) (PDF) | HIM.PA.163 | January 1, 2022 |
Vemurafenib (Zelboraf) (PDF) | CP.PHAR.91 | November 1, 2011 |
Venetoclax (Venclexta) (PDF) | CP.PHAR.129 | September 1, 2018 |
Verteporfin (Visudyne) (PDF) | CP.PHAR.187 | March 1, 2016 |
Vestronidase Alfa-vjbk (Mepsevii) (PDF) | CP.PHAR.374 | January 19, 2018 |
Vigabatrin (Sabril) (PDF) | CP.PHAR.169 | February 1, 2016 |
Vilazodone (Viibryd) (PDF) | CP.PMN.145 | August 1, 2012 |
Viloxazine (Qelbree) (PDF) | CP.PMN.264 | June 1, 2021 |
Viltolarsen (Viltepso) (PDF) | CP.PHAR.484 | August 12, 2020 |
Vincristine Sulfate Liposome Injection (Marqibo) (PDF) | CP.PHAR.315 | February 1, 2017 |
Vismodegib (Erivedge) (PDF) | CP.PHAR.273 | August 1, 2016 |
Voclosporin (Lupkynis) (PDF) | CP.PHAR.504 | September 1, 2020 |
Vorapaxar (Zontivity) (PDF) | HIM.PA.146 | October 31, 2017 |
Voretigene Neparvovec-rzyl (Luxturna) (PDF) | CP.PHAR.372 | March 1, 2018 |
Vorinostat (Zolinza) (PDF) | CP.PHAR.83 | December 1, 2012 |
Vortioxetine (Trintellix) (PDF) | CP.PMN.65 | May 31, 2017 |
Vosoritide (Voxzogo) (PDF) | CP.PHAR.525 | March 1, 2021 |
Voxelotor (Oxbryta) (PDF) | CP.PHAR.451 | March 1, 2020 |
Vutrisiran (Amvuttra) (PDF) | CP.PHAR.550 | December 1, 2021 |
Zanubrutinib (Brukinsa) (PDF) | CP.PHAR.467 | March 1, 2020 |
Ziv-aflibercept (Zaltrap) (PDF) | CP.PHAR.325 | March 1, 2017 |
Zoledronic Acid (Reclast, Zometa) (PDF) | CP.PHAR.59 | March 1, 2011 |